- $13.56m
- $14.14m
- $68.98m
Aterian Inc expected to post a loss of 25 cents a share - Earnings Preview
Brief: Aterian Announces Further Expansion In Europe
Brief: Aterian Inc - Believes Will Further Streamline Its Operations As It Continues To Target Adjusted EBITDA Profitability In Second Half Of 2023
Aterian soars on upbeat Q4 revenue forecast
Brief: Aterian Announces Preliminary Q4 & FY 2022 Net Revenue Results
Brief: Aterian Revenue On Cyber Monday Up About 60% Compared To Last Year's Cyber Monday
U.S. RESEARCH ROUNDUP-Amazon.com, BorgWarner, Cincor pharma
U.S. RESEARCH ROUNDUP-Amyris, HanesBrands, Roblox
U.S. RESEARCH ROUNDUP-Beauty Health, Bioventus, Cabot
Aterian Inc reports results for the quarter ended in September - Earnings Summary
Brief: Aterian Reports Third Quarter 2022 Results
Aterian Inc expected to post a loss of 22 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Microsoft, Oracle, Tesla
U.S. STOCKS ON THE MOVE-Twitter, Ainos, Miniso
U.S. STOCKS ON THE MOVE-Crypto miners, Snow Lake, Daseke, Tesla
Aterian sinks after announcing $20 mln direct offering
Brief: Aterian Inc Sees Q3 Revenue Between $62.0 Mln To $66.0 Mln
Brief: Aterian Inc Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Aterian Inc reports results for the quarter ended in June - Earnings Summary